Lauren Beswick

757 total citations
26 papers, 306 citations indexed

About

Lauren Beswick is a scholar working on Genetics, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Lauren Beswick has authored 26 papers receiving a total of 306 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Genetics, 12 papers in Epidemiology and 5 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Lauren Beswick's work include Inflammatory Bowel Disease (13 papers), Microscopic Colitis (11 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Lauren Beswick is often cited by papers focused on Inflammatory Bowel Disease (13 papers), Microscopic Colitis (11 papers) and Health Systems, Economic Evaluations, Quality of Life (4 papers). Lauren Beswick collaborates with scholars based in Australia, United Kingdom and Italy. Lauren Beswick's co-authors include Daniel R. van Langenberg, Miles Sparrow, Bei Ye, Peter R. Gibson, Christopher Hair, Antony B. Friedman, Gennaro Rosella, Lisa Olive, Subhadra Evans and Antonina Mikocka‐Walus and has published in prestigious journals such as Gastroenterology, Journal of Psychosomatic Research and Alimentary Pharmacology & Therapeutics.

In The Last Decade

Lauren Beswick

24 papers receiving 300 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lauren Beswick Australia 10 174 172 64 49 42 26 306
Mike van der Have Netherlands 9 264 1.5× 239 1.4× 101 1.6× 43 0.9× 29 0.7× 14 400
Joshua D. Noe United States 13 308 1.8× 220 1.3× 84 1.3× 59 1.2× 37 0.9× 35 539
Marjorie Merrick United States 10 209 1.2× 166 1.0× 82 1.3× 53 1.1× 21 0.5× 17 355
Nick Thompson United Kingdom 10 138 0.8× 176 1.0× 105 1.6× 28 0.6× 13 0.3× 26 394
Sally Lawrence Canada 9 260 1.5× 177 1.0× 108 1.7× 34 0.7× 32 0.8× 25 356
Corrie Studd Australia 9 224 1.3× 172 1.0× 130 2.0× 49 1.0× 28 0.7× 12 355
Nienke Ipenburg Netherlands 5 280 1.6× 204 1.2× 99 1.5× 52 1.1× 34 0.8× 7 363
Sheldon Lidofsky United States 5 142 0.8× 119 0.7× 47 0.7× 30 0.6× 16 0.4× 11 227
Karen Frost Canada 7 212 1.2× 162 0.9× 91 1.4× 37 0.8× 11 0.3× 21 361
Jonathan Blackwell United Kingdom 10 245 1.4× 181 1.1× 112 1.8× 31 0.6× 43 1.0× 23 348

Countries citing papers authored by Lauren Beswick

Since Specialization
Citations

This map shows the geographic impact of Lauren Beswick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lauren Beswick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lauren Beswick more than expected).

Fields of papers citing papers by Lauren Beswick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lauren Beswick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lauren Beswick. The network helps show where Lauren Beswick may publish in the future.

Co-authorship network of co-authors of Lauren Beswick

This figure shows the co-authorship network connecting the top 25 collaborators of Lauren Beswick. A scholar is included among the top collaborators of Lauren Beswick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lauren Beswick. Lauren Beswick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Staudacher, Heidi M., Rachelle Opie, Amy Loughman, et al.. (2023). Clinical trial: A Mediterranean diet is feasible and improves gastrointestinal and psychological symptoms in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics. 59(4). 492–503. 33 indexed citations
2.
3.
Skvarc, David, Subhadra Evans, Lisa Olive, et al.. (2022). Can an online expressive writing program support people with inflammatory bowel disease? A feasibility randomised controlled trial. Complementary Therapies in Clinical Practice. 48. 101616–101616. 3 indexed citations
4.
Fuller‐Tyszkiewicz, Matthew, Lauren Beswick, Lisa Olive, et al.. (2021). Low Subjective Wellbeing Is Associated with Psychological Distress in People Living with Inflammatory Bowel Disease. Digestive Diseases and Sciences. 67(6). 2059–2066. 2 indexed citations
5.
Mikocka‐Walus, Antonina, Lisa Olive, David Skvarc, et al.. (2020). Expressive writing to combat distress associated with the COVID-19 pandemic in people with inflammatory bowel disease (WriteForIBD): A trial protocol. Journal of Psychosomatic Research. 139. 110286–110286. 8 indexed citations
6.
Mikocka‐Walus, Antonina, Lauren Beswick, Christian P. Selinger, et al.. (2020). Lived experience in people with inflammatory bowel disease and comorbid anxiety and depression in the United Kingdom and Australia. Journal of Health Psychology. 26(12). 2290–2303. 15 indexed citations
7.
8.
Agirrezabal, Ion, et al.. (2019). PBI35 HEALTH ECONOMICS MODELLING FOR ADVANCED THERAPY MEDICINAL PRODUCTS (ATMP): A TARGETED LITERATURE REVIEW (LR). Value in Health. 22. S423–S423. 1 indexed citations
9.
Vasudevan, Abhinav, Lauren Beswick, Antony B. Friedman, et al.. (2018). Low-dose thiopurine with allopurinol co-therapy overcomes thiopurine intolerance and allows thiopurine continuation in inflammatory bowel disease. Digestive and Liver Disease. 50(7). 682–688. 19 indexed citations
10.
Ward, Mark G., Lauren Beswick, Gennaro Rosella, et al.. (2017). Intra‐patient variability in adalimumab drug levels within and between cycles in Crohn's disease. Alimentary Pharmacology & Therapeutics. 45(8). 1135–1145. 30 indexed citations
11.
Keyte, Rebecca, et al.. (2017). 51 Orkambi: the expectations of benefit for people in the UK with cystic fibrosis. Journal of Cystic Fibrosis. 16. S77–S77. 1 indexed citations
12.
Beswick, Lauren, Ourania Rosella, Gennaro Rosella, et al.. (2017). Exploration of Predictive Biomarkers of Early Infliximab Response in Acute Severe Colitis: A Prospective Pilot Study. Journal of Crohn s and Colitis. 12(3). 289–297. 34 indexed citations
13.
Beswick, Lauren, Bei Ye, & Daniel R. van Langenberg. (2016). Toward an Algorithm for the Diagnosis and Management of CMV in Patients with Colitis. Inflammatory Bowel Diseases. 22(12). 2966–2976. 49 indexed citations
14.
Costello, Samuel P., Simon Ghaly, Lauren Beswick, et al.. (2015). Compassionate access anti‐tumour necrosis factor‐α therapy for ulcerative colitis in Australia: the benefits to patients. Internal Medicine Journal. 45(6). 659–666. 1 indexed citations
15.
Studd, Corrie, Lauren Beswick, Ross Knight, et al.. (2015). Never underestimate inflammatory bowel disease: High prevalence rates and confirmation of high incidence rates in Australia. Journal of Gastroenterology and Hepatology. 31(1). 81–86. 50 indexed citations
16.
Beswick, Lauren, Jamie P. Dwyer, Antony B. Friedman, et al.. (2014). P534 Co-prescription of allopurinol can overcome adverse events of thiopurine therapy and lead to remission in inflammatory bowel disease patients. Journal of Crohn s and Colitis. 8. S290–S291. 1 indexed citations
17.
Beswick, Lauren, Antony B. Friedman, & Miles Sparrow. (2014). The role of thiopurine metabolite monitoring in inflammatory bowel disease. Expert Review of Gastroenterology & Hepatology. 8(4). 383–392. 16 indexed citations
18.
Ghaly, Simon, Samuel P. Costello, Lauren Beswick, et al.. (2014). Dose tailoring of anti‐tumour necrosis factor‐alpha therapy delivers useful clinical efficacy in Crohn disease patients experiencing loss of response. Internal Medicine Journal. 45(2). 170–177. 6 indexed citations
19.
Jackson, B., et al.. (2013). Apparent efficacy and safety of low dose naltrexone in Australian patients with active Crohn's disease. Journal of Gastroenterology and Hepatology. 28. 1 indexed citations
20.
Friedman, N. Deborah, et al.. (2012). Hepatitis C virus treatment in the 'real world': how well do 'real' patients respond?. Journal of Gastroenterology and Hepatology. 27. 181–182. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mike van der Have Breakdown of academic impact, for papers by Joshua D. Noe Breakdown of academic impact, for papers by Marjorie Merrick Breakdown of academic impact, for papers by Nick Thompson Breakdown of academic impact, for papers by Sally Lawrence Breakdown of academic impact, for papers by Corrie Studd Breakdown of academic impact, for papers by Nienke Ipenburg Breakdown of academic impact, for papers by Sheldon Lidofsky Breakdown of academic impact, for papers by Karen Frost Breakdown of academic impact, for papers by Jonathan Blackwell
Rankless by CCL
2026